Overall, these data demonstrated that MASP‐2‐deficient mice are not protected from crescentic glomerulonephritis induced by anti‐MPO antibodies and are in fact predisposed to more severe disease. This evidence concerns the gene MPO and crescentic glomerulonephritis.